Skip to main content

Appili Therapeutics Inc(APLI-T)
TSX

Today's Change
Real-Time Last Update
Volume

Latest News

Closing Bell: Appili Therapeutics Inc flat on Friday (APLI)
The Globe and Mail - Mon Aug 15, 3:01PM CDT
The Globe and Mail
Mon Aug 15, 3:01PM CDT
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2023
Business Wire - Fri Aug 12, 3:54PM CDT
Business Wire
Fri Aug 12, 3:54PM CDT
Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced its financial and operational results for the first...
Appili Therapeutics Inc stock $verbed on Friday.
The Globe and Mail - Fri Aug 12, 3:02PM CDT
The Globe and Mail
Fri Aug 12, 3:02PM CDT
Appili Therapeutics Inc stock $verbed on Thursday.
The Globe and Mail - Thu Aug 11, 3:02PM CDT
The Globe and Mail
Thu Aug 11, 3:02PM CDT
Appili Therapeutics Inc stock dipped on Wednesday.
The Globe and Mail - Wed Aug 10, 3:02PM CDT
The Globe and Mail
Wed Aug 10, 3:02PM CDT
Appili Therapeutics Inc stock advanced on Tuesday.
The Globe and Mail - Tue Aug 9, 3:02PM CDT
The Globe and Mail
Tue Aug 9, 3:02PM CDT
Appili Therapeutics Inc stock dipped on Monday.
The Globe and Mail - Mon Aug 8, 3:02PM CDT
The Globe and Mail
Mon Aug 8, 3:02PM CDT
Appili Therapeutics Inc stock $verbed on Friday.
The Globe and Mail - Fri Aug 5, 3:03PM CDT
The Globe and Mail
Fri Aug 5, 3:03PM CDT
Appili Therapeutics to Present at WorldLeish7 Conference in Cartagena, Columbia
Business Wire - Tue Aug 2, 6:38AM CDT
Business Wire
Tue Aug 2, 6:38AM CDT
Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that Armand Balboni, M.D, Ph.D, Chief Executive Officer,...
Appili Therapeutics Inc stock $verbed on Friday.
The Globe and Mail - Mon Aug 1, 3:15PM CDT
The Globe and Mail
Mon Aug 1, 3:15PM CDT